Laura Benschop1, Sarah Schalekamp-Timmermans1, Zoe A Broere-Brown1, Jeanine E Roeters van Lennep2, Vincent W V Jaddoe3,4, Jolien W Roos-Hesselink5, M Kamran Ikram6, Eric A P Steegers1, James M Roberts7,8, Robin E Gandley7. 1. Departments of Obstetrics and Gynecology (L.B., S.S.-T., Z.A.B.-B., E.A.P.S.), Erasmus Medical Center, Rotterdam, the Netherlands. 2. General Medicine (J.E.R.v.L.), Erasmus Medical Center, Rotterdam, the Netherlands. 3. Epidemiology (V.W.V.J.), Erasmus Medical Center, Rotterdam, the Netherlands. 4. Pediatrics (V.W.V.J.), Erasmus Medical Center, Rotterdam, the Netherlands. 5. CarCardiology (J.W.R.-H.), Erasmus Medical Center, Rotterdam, the Netherlands. 6. Epidemiology and Neurology (M.K.I.), Erasmus Medical Center, Rotterdam, the Netherlands. 7. Magee-Womens Research Institute, Department of Obstetrics and Gynecology and Reproductive Sciences (J.M.R., R.E.G.), University of Pittsburgh, PA. 8. Department of Epidemiology and Clinical and Translational Research (J.M.R.), University of Pittsburgh, PA.
Abstract
BACKGROUND: Angiogenic placental growth factor (PlGF) concentrations rise during pregnancy, peaking at the end of midpregnancy. Low PlGF concentrations during pregnancy are associated with pregnancy complications with recognized later-life cardiovascular risk. We hypothesized that low PlGF concentrations, especially in midpregnancy, identify not only a subset of women at risk for pregnancy complications but also women with greater cardiovascular risk factor burden after pregnancy regardless of pregnancy outcome. METHODS: In a population-based prospective cohort study of 5475 women, we computed gestational age-adjusted multiples of the medians of early pregnancy and midpregnancy PlGF concentrations. Information on pregnancy complications (preeclampsia, small for gestational age, and spontaneous preterm birth) was obtained from hospital registries. Six years after pregnancy, we measured maternal systolic and diastolic blood pressures, cardiac structure (aortic root diameter, left atrial diameter, left ventricular mass, and fractional shortening), carotid-femoral pulse wave velocity, and central retinal arteriolar and venular calibers. Blood pressure was also measured 9 years after pregnancy. RESULTS: Women were on average 29.8 (SD, 5.2) years of age in pregnancy, were mostly European (55.2%), and 14.8% developed a pregnancy complication. Quartile analysis showed that especially women with midpregnancy PlGF in the lowest quartile (the low-PlGF subset) had a larger aortic root diameter (0.40 mm [95% CI, 0.08-0.73]), left atrial diameter (0.34 mm [95% CI, -0.09 to 0.78]), left ventricular mass (4.6 g [95% CI, 1.1-8.1]), and systolic blood pressure (2.3 mm Hg [95% CI, 0.93-3.6]) 6 years after pregnancy than women with the highest PlGF. Linear regression analysis showed that higher midpregnancy PlGF concentrations were associated with a smaller aortic root diameter (-0.24 mm [95% CI, -0.39 to -0.10]), smaller left atrial diameter (-0.75 mm [95% CI, -0.95 to -0.56]), lower left ventricular mass (-3.9 g [95% CI, -5.5 to -2.3]), and lower systolic blood pressure (-1.1 mm Hg [95% CI, -1.7 to -0.46]). These differences persisted after the exclusion of women with complicated pregnancies. CONCLUSIONS: Women with low PlGF in midpregnancy have a greater aortic root diameter, left atrial diameter, and left ventricular mass and higher systolic blood pressure 6 and 9 years after pregnancy compared to women with higher PlGF, including women with uncomplicated pregnancies. The pathophysiological implications of lower PlGF concentrations in midpregnancy might provide insight into the identification of pathways contributing to greater cardiovascular risk factor burden.
BACKGROUND: Angiogenic placental growth factor (PlGF) concentrations rise during pregnancy, peaking at the end of midpregnancy. Low PlGF concentrations during pregnancy are associated with pregnancy complications with recognized later-life cardiovascular risk. We hypothesized that low PlGF concentrations, especially in midpregnancy, identify not only a subset of women at risk for pregnancy complications but also women with greater cardiovascular risk factor burden after pregnancy regardless of pregnancy outcome. METHODS: In a population-based prospective cohort study of 5475 women, we computed gestational age-adjusted multiples of the medians of early pregnancy and midpregnancy PlGF concentrations. Information on pregnancy complications (preeclampsia, small for gestational age, and spontaneous preterm birth) was obtained from hospital registries. Six years after pregnancy, we measured maternal systolic and diastolic blood pressures, cardiac structure (aortic root diameter, left atrial diameter, left ventricular mass, and fractional shortening), carotid-femoral pulse wave velocity, and central retinal arteriolar and venular calibers. Blood pressure was also measured 9 years after pregnancy. RESULTS:Women were on average 29.8 (SD, 5.2) years of age in pregnancy, were mostly European (55.2%), and 14.8% developed a pregnancy complication. Quartile analysis showed that especially women with midpregnancy PlGF in the lowest quartile (the low-PlGF subset) had a larger aortic root diameter (0.40 mm [95% CI, 0.08-0.73]), left atrial diameter (0.34 mm [95% CI, -0.09 to 0.78]), left ventricular mass (4.6 g [95% CI, 1.1-8.1]), and systolic blood pressure (2.3 mm Hg [95% CI, 0.93-3.6]) 6 years after pregnancy than women with the highest PlGF. Linear regression analysis showed that higher midpregnancy PlGF concentrations were associated with a smaller aortic root diameter (-0.24 mm [95% CI, -0.39 to -0.10]), smaller left atrial diameter (-0.75 mm [95% CI, -0.95 to -0.56]), lower left ventricular mass (-3.9 g [95% CI, -5.5 to -2.3]), and lower systolic blood pressure (-1.1 mm Hg [95% CI, -1.7 to -0.46]). These differences persisted after the exclusion of women with complicated pregnancies. CONCLUSIONS:Women with low PlGF in midpregnancy have a greater aortic root diameter, left atrial diameter, and left ventricular mass and higher systolic blood pressure 6 and 9 years after pregnancy compared to women with higher PlGF, including women with uncomplicated pregnancies. The pathophysiological implications of lower PlGF concentrations in midpregnancy might provide insight into the identification of pathways contributing to greater cardiovascular risk factor burden.
Authors: Kristiina L Aasa; Bruno Zavan; Rayana L Luna; Philip G Wong; Nicole M Ventura; M Yat Tse; Peter Carmeliet; Michael A Adams; Stephen C Pang; B Anne Croy Journal: Biol Reprod Date: 2014-12-23 Impact factor: 4.285
Authors: Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi Journal: J Clin Invest Date: 2003-03 Impact factor: 14.808
Authors: Richard J Levine; Sharon E Maynard; Cong Qian; Kee-Hak Lim; Lucinda J England; Kai F Yu; Enrique F Schisterman; Ravi Thadhani; Benjamin P Sachs; Franklin H Epstein; Baha M Sibai; Vikas P Sukhatme; S Ananth Karumanchi Journal: N Engl J Med Date: 2004-02-05 Impact factor: 91.245
Authors: R Orabona; E Vizzardi; E Sciatti; I Bonadei; A Valcamonico; M Metra; T Frusca Journal: Ultrasound Obstet Gynecol Date: 2017-01 Impact factor: 7.299
Authors: Frank T Spradley; Adelene Y Tan; Woo S Joo; Garrett Daniels; Paul Kussie; S Ananth Karumanchi; Joey P Granger Journal: Hypertension Date: 2016-02-01 Impact factor: 10.190
Authors: Laura Ormesher; Suzanne Higson; Matthew Luckie; Stephen A Roberts; Heather Glossop; Andrew Trafford; Elizabeth Cottrell; Edward D Johnstone; Jenny E Myers Journal: Hypertension Date: 2020-10-05 Impact factor: 10.190
Authors: Eduardo Carvalho de Arruda Veiga; Paulo Ricardo Higassiaraguti Rocha; Leonardo L Caviola; Viviane Cunha Cardoso; Fabricio da Silva Costa; Maria da Conceição Pereira Saraiva; Marco Antonio Barbieri; Heloisa Bettiol; Ricardo Carvalho Cavalli Journal: Clinics (Sao Paulo) Date: 2021-01-20 Impact factor: 2.365
Authors: Megan A Opichka; Matthew W Rappelt; David D Gutterman; Justin L Grobe; Jennifer J McIntosh Journal: Cells Date: 2021-11-06 Impact factor: 7.666
Authors: Samantha J Benton; Erika E Mery; David Grynspan; Laura M Gaudet; Graeme N Smith; Shannon A Bainbridge Journal: J Clin Med Date: 2022-03-13 Impact factor: 4.241